Taken together, the coordinated transcriptional reprogramming characterized by p53 upregulation, Bcl-2 downregulation, and ND3 downregulation orchestrates apoptosis in BGNps-treated triple-negative MDA-MB-231 breast cancer cells. The gene discussed is MT-ND3; the disease is breast carcinoma.